{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Quanterix Corporation"},"Symbol":{"label":"Symbol","value":"QTRX"},"Address":{"label":"Address","value":"900 MIDDLESEX TURNPIKE,BUILDING 1, BILLERICA, Massachusetts, 01821, United States"},"Phone":{"label":"Phone","value":"+1 617 301-9400"},"Industry":{"label":"Industry","value":"Biotechnology: Laboratory Analytical Instruments"},"Sector":{"label":"Sector","value":"Industrials"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability."},"CompanyUrl":{"label":"Company Url","value":"https://www.quanterix.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alexandra Phillips","title":"Chief Information Officer & Senior Vice President"},{"name":"David C. Duffy","title":"Chief Technology Officer & Vice President-Research"},{"name":"Mark T. Roskey","title":"Chief Science & Collaboration Officer"},{"name":"Masoud Toloue","title":"President, Chief Executive Officer & Director"},{"name":"Michael F. Miller","title":"Chief Operating Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}